市場調查報告書
商品編碼
1470871
呼吸照護設備市場:按產品、適應症和最終用戶分類 - 全球預測 2024-2030Respiratory Care Devices Market by Product (Consumables & Accessories, Diagnostic Devices, Monitoring Devices), Indication (Asthma, Chronic Obstructive Pulmonary Disease, Infectious Disease), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年呼吸護理設備市場規模為198.7億美元,預計2024年將達210.8億美元,2030年預計將達306.6億美元,複合年成長率為6.39%。
呼吸照護設備市場包括用於診斷、監測、治療和管理呼吸系統疾病的各種醫療設備、裝置和消耗品。這些醫療設備用於為有長期照護需求的患者提供醫療保健環境,包括醫院、診所、門診手術中心和居家照護。推動呼吸照護設備市場的主要因素是由於空氣污染水平上升和菸草使用增加導致呼吸系統疾病盛行率上升,導致慢性阻塞性肺病和氣喘病例。該市場成長面臨的限制和挑戰包括與先進醫療設備相關的高成本,這限制了可及性,以及由於複雜設備的不當處理或濫用而導致併發症和感染疾病的風險。市場開拓公司專注於開發緊湊且易於使用的攜帶式設備。此外,透過將先進技術整合到呼吸護理解決方案中,對具有更高耐用性和數位連接性的輕質部件進行材料科學研究,以改善患者照護的協調性,這將為全球呼吸護理設備市場帶來機遇。
主要市場統計 | |
---|---|
基準年[2023] | 198.7億美元 |
預測年份 [2024] | 210.8億美元 |
預測年份 [2030] | 306.6億美元 |
複合年成長率(%) | 6.39% |
產品對呼吸照護設備的基本消耗品和配件的需求不斷增加
耗材和配件是呼吸照護設備有效運作的重要組成部分。這包括呼吸管路、一次性口罩、氧氣鼻管、氣切管等。所有類別的消耗品和配件都有很高的需求,因為它們必須經常更換,以保持衛生並防止需要呼吸支持的患者感染的風險。診斷設備透過測量肺活量、氣道阻力和氣體交換效率來識別氣喘、慢性阻塞性肺病(COPD) 和睡眠呼吸中止症等呼吸系統疾病至關重要。常見的診斷工具包括肺計量計、睡眠多項生理檢查(PSG) 和峰值流量計 (PFM)。此監測設備使用各種感測器來追蹤患者的呼吸模式,並將資料發送給醫療保健專業人員,以即時分析氧氣水平和氣流阻塞事件。此類設備包括脈動式血氧監測儀系統和氣體分析儀。治療設備為呼吸衰竭患者提供持續或間歇性支持,並提供氧氣療法治療、非侵入性通氣 (NIV)、機械通氣、霧化器和加濕器等治療選擇。
適應族群中呼吸道疾病的盛行率增加
氣喘是一種慢性肺部疾病,其特徵是氣道發炎,導致喘息、咳嗽、氣短和胸悶。為氣喘開發的呼吸護理設備包括吸入器、霧化器和峰值流量計。慢性阻塞性肺病(COPD)是一組進行性肺部疾病,患者氣流因暴露於空氣污染和香菸煙霧等刺激物而受阻。常見症狀包括咳嗽、氣短、喘息並伴隨黏液和胸悶。用於 COPD 管理的呼吸護理設備包括氧氣濃縮機、人工呼吸器、正壓呼吸器(PAP)設備和脈動式血氧監測儀系統。結核病和肺炎等呼吸道感染疾病需要特定的呼吸照護設備,例如高流量氧氣鼻管(HFNC)治療系統和機械人工呼吸器,以在嚴重感染疾病期間支持呼吸。睡眠呼吸中止症是一種睡眠障礙,其特徵是呼吸模式中斷,導致睡眠品質不佳和白天疲勞。 CPAP(持續性正壓呼吸器)機器是治療睡眠呼吸中止症的常見治療方法,可維持持續氣流以防止睡眠期間氣道塌陷。
最終用戶:對具有遠端監控功能的易於使用的設備的需求不斷成長,以提高居家照護環境中患者的用藥依從性。
由於需要定期監測和治療的呼吸系統疾病患者數量不斷增加,門診醫療中心對呼吸照護設備的需求不斷增加。門診醫療中心使用的設備包括霧化器、氧氣濃縮機、脈動式血氧監測儀系統和人工呼吸器。居家醫療涉及患者在自己的家中單獨或在經過培訓的看護者的幫助下使用呼吸護理設備。家庭醫療保健的成長趨勢增加了對易於使用的可攜式呼吸器的需求,這些呼吸器可以由患者和看護者輕鬆操作。由於大量患者需要加護治療、術後護理和緊急呼吸支持,醫院和診所是呼吸護理設備的重要最終用戶區域。
區域洞察
由於一般民眾對各種呼吸系統疾病的認知不斷提高以及該地區主要企業的存在,美洲呼吸照護設備市場正在經歷成長。推動這一成長的因素包括醫療基礎設施的改善、有利的報銷政策以及市場參與企業更多地採用先進技術。在歐洲、中東和非洲地區,由於人口老化,更容易患慢性阻塞性肺病(COPD)等慢性呼吸道疾病,呼吸照護設備市場正在顯著擴大。此外,旨在降低醫療保健成本的政府措施正在推動該地區家庭呼吸護理設備的採用。此外,中東地區政府對醫療基礎設施的支出增加正在推動歐洲、中東和非洲地區對呼吸照護設備的需求。亞太地區是全球呼吸照護設備市場成長最快的地區之一。由於人口快速成長,中國、印度和日本的慢性呼吸道疾病正在迅速增加。此外,亞太地區主要城市的空氣污染程度較高,導致居民呼吸道疾病的盛行率增加。再加上醫療基礎設施的改善、人們對呼吸道疾病的認知不斷提高以及可支配收入的增加,正在推動該地區的市場成長。
FPNV定位矩陣
FPNV定位矩陣對於評估呼吸照護設備市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對呼吸照護設備市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.呼吸護理設備市場的市場規模與預測是多少?
2.呼吸照護設備市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.呼吸護理設備市場的技術趨勢和法規結構是什麼?
4.呼吸護理設備市場主要廠商的市場佔有率為何?
5.進入呼吸照護設備市場合適的型態和策略手段是什麼?
[189 Pages Report] The Respiratory Care Devices Market size was estimated at USD 19.87 billion in 2023 and expected to reach USD 21.08 billion in 2024, at a CAGR 6.39% to reach USD 30.66 billion by 2030.
The respiratory care devices market encompasses various medical devices, equipment, and consumables utilized for the diagnosis, monitoring, treatment, and management of respiratory diseases. These devices are employed in healthcare settings, including hospitals, clinics, ambulatory surgical centers, and homecare situations by patients who require long-term care. Key factors driving the respiratory care devices market are the rising prevalence of respiratory diseases owing to increasing air pollution levels and tobacco usage, leading to COPD and asthma cases. Limitations & challenges faced by the growth of this market include high costs associated with advanced medical equipment limiting accessibility and risk of complications or infections due to improper handling or misuse of complex devices. Market companies are focusing on developing compact, user-friendly portable devices. Moreover, research into material science for lighter-weight components with improved durability and digital connectivity enabling improved patient care coordination by integrating advanced technologies into respiratory care solutions is creating lucrative opportunities for the global respiratory care devices market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 19.87 billion |
Estimated Year [2024] | USD 21.08 billion |
Forecast Year [2030] | USD 30.66 billion |
CAGR (%) | 6.39% |
Product: Growing need for essential consumables and accessories for respiratory care devices
Consumables and accessories are essential components for the effective functioning of respiratory care devices. These include breathing circuits, disposable masks, nasal cannulas, and tracheostomy tubes. Consumables and accessories are highly demanded across all categories owing to their frequent replacement need to maintain hygiene and prevent infection risks in patients who require respiratory support. Diagnostic devices are crucial in identifying respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and other breathing issues by measuring lung volume, airway resistance, and gas exchange efficiency. Common diagnostic tools include spirometers, polysomnographs (PSG), and peak flow meters (PFM). Monitoring devices track a patient's breathing patterns using various sensors that transmit data to healthcare professionals for real-time analysis of oxygen levels or airflow obstruction events. These devices include pulse oximeters and gas analyzers. Therapeutic devices facilitate continuous or intermittent support for patients with respiratory insufficiency, offering treatment options such as oxygen therapy, non-invasive ventilation (NIV), mechanical ventilation, nebulizers, and humidifiers.
Indication: Rising prevalence of respiratory disorders among population
Asthma is a type of chronic lung disease characterized by airway inflammation, leading to wheezing, coughing, shortness of breath, and chest tightness. Respiratory care devices designed for asthma include inhalers, nebulizers, and peak flow meters. Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that obstruct airflow owing to exposure to irritants such as air pollution or tobacco smoke. Common symptoms include coughing, shortness of breath, wheezing with mucus, and chest tightness. Respiratory care devices for COPD management include oxygen concentrators, ventilators, positive airway pressure (PAP) devices, and pulse oximeters. Respiratory infectious diseases such as tuberculosis or pneumonia require specific respiratory care devices, including high-flow nasal cannula (HFNC) therapy systems or mechanical ventilators to support breathing during severe infections. Sleep apnea is a sleep disorder characterized by interrupted breathing patterns leading to poor-quality sleep and daytime fatigue. Continuous Positive Airway Pressure (CPAP) devices is the common treatment for sleep apnea that maintain continuous airflow to prevent airway collapse during sleep.
End-User: Emerging demand for user-friendly devices with remote monitoring capabilities to facilitate better patient adherence in home care settings
Ambulatory care centers have an increasing demand for respiratory care devices owing to the growing number of patients with respiratory conditions who require regular monitoring and treatment. The equipment used in ambulatory care centers includes nebulizers, oxygen concentrators, pulse oximeters, and ventilators. Home care settings involve the use of respiratory care devices by patients at home, either independently or with assistance from trained caregivers. The increasing trend towards home healthcare has led to a rise in demand for user-friendly and portable respiratory devices that can be easily operated by both patients and their caregivers. Hospitals and clinics represent a significant end-user segment for respiratory care devices owing to the high volume of patients requiring intensive care, post-operative care, or emergency respiratory support.
Regional Insights
The Americas has experienced growth in its respiratory care devices market owing to increasing awareness regarding various respiratory disorders among the general population and the strong presence of key market companies in this region. Factors driving this growth include improving healthcare infrastructure, favorable reimbursement policies, and the growing adoption of advanced technologies by market players. The EMEA region has seen significant expansion within its respiratory care devices market owing to an aging population prone to chronic respiratory diseases, including COPD. Furthermore, government initiatives aimed at reducing healthcare costs are encouraging the adoption of home respiratory care devices within this region. Furthermore, increased government spending on healthcare infrastructure in the Middle East region has augmented the demand for respiratory care devices within EMEA. APAC is expected to be one of the fastest-growing regions in the global respiratory care devices market. The rapidly increasing population in China, India, and Japan has led to a surge in chronic respiratory diseases. Additionally, high air pollution levels in major cities across Asia-Pacific are contributing to an increased prevalence of respiratory ailments among its residents. This, coupled with improving healthcare infrastructure, growing awareness about respiratory disorders among the populace, and rising disposable incomes, have fostered market growth within this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Respiratory Care Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Respiratory Care Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Respiratory Care Devices Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Allied Medical LLC, Baxter International, Inc., Catalent, Inc., Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Flexicare (Group) Limited, GE HealthCare Technologies Inc., Getinge AB, Hamilton Medical AG, Invacare Corporation, Koninklijke Philips N.V., Leistung, L'Air Liquide S.A., Masimo Corp., Max Ventilator by A.B.Industries, Medline Industries, LP, Medtechlife, Medtronic PLC, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Corporation, React Health, ResMed Corp., Schiller AG, Smiths Group PLC, Teleflex Incorporated, Thermo Fisher Scientific Inc., Vyaire Medical, Inc., and ZOLL Medical Corporation by Asahi Kasei Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Respiratory Care Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Respiratory Care Devices Market?
3. What are the technology trends and regulatory frameworks in the Respiratory Care Devices Market?
4. What is the market share of the leading vendors in the Respiratory Care Devices Market?
5. Which modes and strategic moves are suitable for entering the Respiratory Care Devices Market?